Novacap SAS Acquires PCI Synthesis

ID
123436

DATE

2018-06-20

target

PCI Synthesis, Inc.

Newburyport, Massachusetts
United States
www.pcisynthesis.com
PCI Synthesis, Inc. is a Pharmaceutical Development CDMO (Contract Development and Manufacturing Organization) based in Newburyport, MA and is the largest small molecule drug substance manufacturer in the New England area. PCI Synthesis is also a commercial manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products for the medical device industry.
(Show More)

Search 122,781 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Get Started

Acquirer 1

Acquirer DESCRIPTION

Novacap SAS

COMPANY
Cedex
France
www.novacap.eu

Novacap SAS

Novacap is a global diversified chemicals Group that produces and distributes essential chemicals that are used in everyday products. It enjoys leading positions in its target growth end-markets of pharmaceuticals & healthcare, food & feed, cosmetics & fragrances, home care and environment.


DEAL STATS #
Acquisition 3 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 3 of 3
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2018) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-22 Chemoxy International Ltd. Buy -